{"id":"W2316235102","doi":"10.1155/2002/164302","title":"Funding the New Biologics – A Health Economic Critique of the CCOHTA Report: Infliximab for the Treatment of Crohn’s Disease","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Infliximab; Medicine; Crohn's disease; Health care; Quality-adjusted life year; Economic evaluation; Disease; Cost–benefit analysis; Actuarial science; Intensive care medicine; Cost effectiveness; Business; Risk analysis (engineering); Economics; Economic growth; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08526064,0.001162673,0.001929997,0.003739692,0.00337681,0.01100136,0.005390263,0.02533451,0.004838204],"category_scores_gemma":[0.3215407,0.0007531217,0.002365346,0.004624954,0.008807175,0.005655447,0.004555566,0.03115147,0.001806903],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01870874,"about_ca_system_score_gemma":0.05444982,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1069169,"about_ca_topic_score_gemma":0.06725742,"domain_scores_codex":[0.879886,0.04641997,0.007679854,0.004173859,0.0572149,0.004625424],"domain_scores_gemma":[0.5971633,0.2850309,0.01229475,0.00721592,0.09077115,0.00752405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002067429,0.00002914123,0.000656542,0.0007047827,0.0001035693,0.0001269826,0.0005515446,0.0007185911,0.00008887838,0.1188703,0.8299039,0.04803909],"study_design_scores_gemma":[0.0003663313,0.00008166565,0.001834426,0.004717344,0.0001747407,0.0003022417,0.0004428337,0.001636723,0.0003055069,0.05194624,0.9380264,0.0001654943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.0005755863,0.008534971,0.0006918728,0.9685905,0.01288187,0.00003400908,0.0002486909,0.00003518243,0.008407289],"genre_scores_gemma":[0.04246082,0.01489394,0.004380598,0.8720671,0.05585979,0.0004077578,0.0004339145,0.0002280058,0.009268111],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9812912,"threshold_uncertainty_score":0.4509068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2644395043441017,"score_gpt":0.3888988812456913,"score_spread":0.1244593769015896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}